Producing sperms and eggs from iPSC
        Katsuhiko Hayashi, Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Japan

Development of primordial follicles
        Teresa Woodruff, Thomas J. Watkins Professor of Obstetrics & Gynecology, Feinberg School of Medicine and
         Professor of Biochemistry, Molecular Biology and Cell Biology, Weinberg College of Arts and Sciences, USA

Spermatogonal stem cell culture in prepubertal boys and cancer
        Sjoerd Repping, Professor of Human Reproductive Biology, Academic Medical Center, University of Amsterdam, the Netherlands

Human ovarian cryobanking: Science and clinical practice
        Samuel Kim, President of the International Society on Fertiliity Preservation; Division Head, Professor, University of Kansas,
         Dept of OB/GYN, USA

Cryobiology
        Masashige Kuwayama, CEO, Repro-Support Medical Research Centre, Japan

Preservation of ovaries and ovarian transplantation
        Sherman Silber, Director, Infertility Center of St. Louis, USA

IVM in fertility preservation
        SL Tan, Professor and Chairman, Department of Obstetrics and Gynecology, McGill University, Canad

Single cell complete gene sequencing for cancer
        Beijing Genomic Institution


College / Program Max. for whole function 1 Feb 2 Feb 3 Feb CME / CPD Category Other Conditions
Community Medicine 10 3 6 6    
Family Physicians 10 5 5 5 Cat 5.2  
Obstetricians & Gynaecologists Pending    
Pathologists 16.5 4.5 6.5 5.5    
Physicians   3 4.5 3.5    
Radiologists 15 4 6 5 Cat B  
Surgeons 16 4.5 6 5.5 Passive  
MCHK CME Programme 10 5 5 5 Passive Accredited by HKAM

The International Conference on Preservation of Fertility for Cancer Patients (PFCP 2013) will be held in Hong Kong from 1-3 February 2013. On behalf of the Organizing Committee, we cordially invite you to join this conference which is hosted by The Hong Kong Society for Reproductive Medicine and endorsed by the International Society for Fertility Preservation.

Cancer is increasing in prevalence and concurrently its treatment is also of increasing success. The age of onset, especially in the commonest cancer in women, namely breast cancer, is getting younger and younger. Thus, the request for preserving a woman's fertility is increasingly common and also more important. At the same time, just as treatment success is a reality, medical treatment and technologies for effectively providing fertility preservation advances. It is now possible to store sperm, eggs, embryos, even part of or whole organs and then use them to produce children for those who recover from their diseases. But this is not restricted to women of reproductive years, patients of both sexes in all age groups can benefit.

The PFCP 2013 will have a collection of the best scientists and clinicians in this field, and will present a cutting edge view of the current knowledge and practice. For the interest of all doctors, especially those in Asia, this is the first opportunity to meet the experts and learn at first hand the basic sciences and clinical modalities of fertility preservation. The conference will be an excellent occasion to get updated on novel discoveries and techniques.

Besides participating in the conference, having a glimpse of the city is always a tempting idea. Hong Kong is a vibrant cosmopolitan city with unique opportunities for sightseeing, shopping, dining and entertainment. We are sure that you will have a wonderful time here!

We look forward to welcoming you to Hong Kong in 2013.

Prof. Milton Leong                  Prof. Sherman Silber
Co-chairpersons, Organizing Committee

 


癌症患者生育保存國際會議2013:中文資訊請按下載
Announcement flyer is now available! Please click here to download.

Abstract submission deadline is extended to 1 January 2013. Please click here to submit your abstract.

Online registration is launched. Please click here to register.

 

 
All rights reserved © 2012 PFCP2013